NewAmsterdam Pharma Co N.V.
NAMSW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.
Other share classesNAMS
Q4 2024 vs. Q3 2024
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 1.33M | 1.32M | −10.7K (−0.8%) |
| Value | $9.32M | $18.8M | +$9.44M (+101.3%) |
New holders (2)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wolverine Asset Management LLC | 12,693 | $180.9K | 0.00% |
| UBS Group AG | 2,481 | $35.4K | 0.00% |
Sold out (2)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Monashee Investment Management LLC | 31,189 | $218.3K |
| TFC Financial Management | 6,181 | $43.3K |